TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14967569

Group type: EXPERIMENTAL
Intervention: isokinetic techniques
Number of subjects: 17

Group type: COMPARATOR
Intervention: standard physiotherapy
Number of subjects: 17
Study: 11554217

Group type: EXPERIMENTAL
Intervention: ArginMax
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 9598520

Group type: EXPERIMENTAL
Intervention: Olympus prototype model A2186 resectoscope loop
Number of subjects: 226

Group type: COMPARATOR
Intervention: Conventional resectoscope loop
Number of subjects: 226
Study: 7841660

Group type: EXPERIMENTAL
Intervention: Cigarette smoke exposure
Number of subjects: 57
Study: 3212403

Group type: EXPERIMENTAL
Intervention: Immunosuppressive drug therapy with long-term plasmapheresis
Number of subjects: 15

Group type: COMPARATOR
Intervention: Immunosuppressive drug therapy
Number of subjects: 15
Study: 30624250

Group type: EXPERIMENTAL
Intervention: Mobile device application for PFMT
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group with written instructions
Number of subjects: 21
Study: 30029486

Group type: EXPERIMENTAL
Intervention: 8-week exercise plus compensatory eating avoidance program (CEAP; n = 24)
Number of subjects: 45

Group type: COMPARATOR
Intervention: 8-week exercise intervention only (control; n = 21)
Number of subjects: 45
Study: 27283367

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) plus narrow-band UVB phototherapy for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Narrow-band UVB phototherapy for 8 weeks (control group)
Number of subjects: 40
Study: 25703666

Group type: EXPERIMENTAL
Intervention: rhGM‐CSF hydrogel
Number of subjects: 21

Group type: COMPARATOR
Intervention: mupirocin ointment
Number of subjects: 21
Study: 24335927

Group type: EXPERIMENTAL
Intervention: Kegel exercise intervention group
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 12
Study: 20461001

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion (target concentrations: 4-9 ng/ml; infusion rates: 0.17-9 ng x ml x min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion with low-dose propofol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Simulation study at varying remifentanil infusion speeds
Number of subjects: 10
Study: 17901910

Group type: EXPERIMENTAL
Intervention: Polypropylene mesh surgery
Number of subjects: 90

Group type: COMPARATOR
Intervention: Site-specific surgery
Number of subjects: 90
Study: 16390895

Group type: EXPERIMENTAL
Intervention: Fluoxetine or Nortriptyline
Number of subjects: 175
Study: 14638885

Group type: EXPERIMENTAL
Intervention: Pyridostigmine 60 mg four times a day for 14 weeks
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 10822283

Group type: EXPERIMENTAL
Intervention: Extruded dry beans (110 g/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control diet (no dry beans)
Number of subjects: 22
Study: 8864326

Group type: EXPERIMENTAL
Intervention: Lignocaine + Clonidine
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Lignocaine + Adrenaline
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Lignocaine + Adrenaline + Clonidine
Number of subjects: 4

Group type: COMPARATOR
Intervention: Plain Lignocaine
Number of subjects: 4
Study: 1623914

Group type: EXPERIMENTAL
Intervention: Ketoprofen (25 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ibuprofen (200 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Aspirin (500 mg)
Number of subjects: 12
Study: 6379871

Group type: EXPERIMENTAL
Intervention: Broncho-Vaxom
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study: 31701568

Group type: EXPERIMENTAL
Intervention: High scores on General Attractiveness Subscale for sunbathing
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Age 18-25 years for sunbed use
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: High scores on General Attractiveness Subscale for sunbed use
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Low risk perception of UVR
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Risk perception of UVR
Number of subjects: 3000
Study: 30892676

Group type: EXPERIMENTAL
Intervention: Ketamine infusion (Group K)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lidocaine infusion (Group L)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (0.9% sodium chloride infusion)
Number of subjects: 100
Study: 28183568

Group type: EXPERIMENTAL
Intervention: Play dough (group PD)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 104
Study: 26242010

Group type: EXPERIMENTAL
Intervention: SRP + SZ
Number of subjects: 64

Group type: COMPARATOR
Intervention: SRP + placebo
Number of subjects: 64
Study: 24342500

Group type: EXPERIMENTAL
Intervention: ACLR
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: ACLD
Number of subjects: 59

Group type: COMPARATOR
Intervention: CONT
Number of subjects: 59
Study: 21996573

Group type: EXPERIMENTAL
Intervention: Selective supraomohyoid neck dissection with level IIb
Number of subjects: 57

Group type: COMPARATOR
Intervention: Selective supraomohyoid neck dissection without level IIb
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: EMG or NCS data on trapezius muscle activity
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: University of Washington quality of life scale (UWQoLv4)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Neck dissection impairment index (NDII)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Range of movement
Number of subjects: 57
Study: 19541265

Group type: EXPERIMENTAL
Intervention: Weekend atropine plus full spectacle correction for the sound eye
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Weekend atropine plus plano lens
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Weekend atropine
Number of subjects: 100

Group type: COMPARATOR
Intervention: 2 hours of daily patching
Number of subjects: 100
Study: 17382157

Group type: EXPERIMENTAL
Intervention: Local anesthetic
Number of subjects: 994

Group type: COMPARATOR
Intervention: Placebo or nothing
Number of subjects: 994
Study: 15314339

Group type: EXPERIMENTAL
Intervention: Aroma-sitz bath group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aroma-soap application group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 11098943

Group type: EXPERIMENTAL
Intervention: Dispatcher-assisted CPR with chest compression only
Number of subjects: 520

Group type: COMPARATOR
Intervention: Standard instructions for airway maintenance ventilation and chest compression (control)
Number of subjects: 520
Study: 9262035

Group type: EXPERIMENTAL
Intervention: K every 24 hr
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: K every 12 hr
Number of subjects: 152

Group type: COMPARATOR
Intervention: MSC every 12 hr
Number of subjects: 152
Study: 8316267

Group type: EXPERIMENTAL
Intervention: Directional atherectomy
Number of subjects: 274

Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 274
Study: 3333162

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1200 mg/day per os, Trental 400 t.i.d.)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 60
Study: 30513727

Group type: EXPERIMENTAL
Intervention: 4 cups of coffee/day
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 8 cups of coffee/day
Number of subjects: 47

Group type: COMPARATOR
Intervention: No coffee consumption (control phase)
Number of subjects: 47
Study: 25520035

Group type: EXPERIMENTAL
Intervention: Robotically assisted body weight supported treadmill training (RABWSTT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Home stretching program (HSP)
Number of subjects: 18
Study: 25002731

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 16 mg twice daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 50
Study: 22943199

Group type: EXPERIMENTAL
Intervention: Infliximab/MTX in late RA
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Infliximab/MTX in early RA
Number of subjects: 3

Group type: COMPARATOR
Intervention: Methotrexate and methylprednisolone in early RA (control group)
Number of subjects: 3
Study: 20691042

Group type: EXPERIMENTAL
Intervention: Six-months physical training with active and/or assisted cycling training equipment for ambulant and recently wheelchair‐dependent boys with DMD.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Six-months physical training program consisting of computer‐assisted training and functional training with arm support for boys with DMD confined to a wheelchair.
Number of subjects: 40
Study: 18655528

Group type: EXPERIMENTAL
Intervention: Intense combined 3-month familial dietary-behavioral-physical activity intervention
Number of subjects: 22
Study: 15957666

Group type: EXPERIMENTAL
Intervention: Intensified screening using Timeline Followback (TLFB) interview and Alcohol Use Disorder Inventory Test (AUDIT)
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Intensified screening using AUDIT
Number of subjects: 303

Group type: COMPARATOR
Intervention: Regular antenatal care (control)
Number of subjects: 303
Study: 15320473

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparins (LMWH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfractionated heparin (UH)
Number of subjects: 0
Study: 10958880

Group type: EXPERIMENTAL
Intervention: Natural rubber latex condom
Number of subjects: 54

Group type: COMPARATOR
Intervention: Polyurethane condom
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: New non-latex (SEBS) condom
Number of subjects: 54
Study: 8962549

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy for acute myocardial infarction
Number of subjects: 0
Study: 1835229

Group type: EXPERIMENTAL
Intervention: Hepatitis B immunoglobulin (HBIg) and recombinant hepatitis B vaccine (HBvaxDNA) with an intensive schedule (0, 1 months for HBIg; 0, 1, 2, 6 months for vaccine)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Hepatitis B immunoglobulin (HBIg) and recombinant hepatitis B vaccine (HBvaxDNA) for males
Number of subjects: 175

Group type: COMPARATOR
Intervention: Control group (hospital personnel immunized with HBvaxDNA without HBIg, regular schedule 0, 1, 6 months)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Geometric mean titre for female patients
Number of subjects: 175

Group type: COMPARATOR
Intervention: Geometric mean titre for female controls
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Geometric mean titre for male patients
Number of subjects: 175

Group type: COMPARATOR
Intervention: Geometric mean titre for male controls
Number of subjects: 175
Study: 6188917

Group type: EXPERIMENTAL
Intervention: metoprolol (average 179 mg/day)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: pindolol (average 12 mg/day)
Number of subjects: 36
Study: 30316694

Group type: EXPERIMENTAL
Intervention: Video education
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Written education
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 29866127

Group type: EXPERIMENTAL
Intervention: Educational intervention based on the RANAS model
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Direct-delivery refueling service
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Combined intervention (educational + delivery)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Control arm (no intervention)
Number of subjects: 900
Study: 26759975

Group type: EXPERIMENTAL
Intervention: RAD US
Number of subjects: 2759

Group type: EXPERIMENTAL
Intervention: POC US
Number of subjects: 2759

Group type: EXPERIMENTAL
Intervention: CT
Number of subjects: 2759
Study: 24793257

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: Counselling
Number of subjects: 755

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 755
Study: 21452177

Group type: EXPERIMENTAL
Intervention: Disengagement strategies
Number of subjects: 271

Group type: COMPARATOR
Intervention: Engagement strategies
Number of subjects: 271
Study: 19838759

Group type: EXPERIMENTAL
Intervention: RYGB followed by standardized caloric restriction
Number of subjects: 22

Group type: COMPARATOR
Intervention: Caloric restriction alone (diet)
Number of subjects: 22
Study: 18060965

Group type: EXPERIMENTAL
Intervention: Abdominal sacrocolpopexy with Burch colposuspension
Number of subjects: 305

Group type: COMPARATOR
Intervention: Abdominal sacrocolpopexy without Burch colposuspension
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Both groups (with and without Burch)
Number of subjects: 305
Study: 15619406

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stent (EES)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Metallic stent
Number of subjects: 42
Study: 11901445

Group type: EXPERIMENTAL
Intervention: Single dose of 3200 microg of budesonide
Number of subjects: 19

Group type: COMPARATOR
Intervention: Usual care plus placebo
Number of subjects: 19
Study: 9740606

Group type: EXPERIMENTAL
Intervention: Lisinopril (n=84)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Lisinopril plus hydrochlorothiazide (n=91)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Lisinopril and Lisinopril plus hydrochlorothiazide
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: T/P >/=0.5 or <0.5
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: T/Ps
Number of subjects: 175
Study: 7598069

Group type: EXPERIMENTAL
Intervention: High-fat diet (50% of energy as fat)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Low-fat diet (25% of energy as fat)
Number of subjects: 6
Study: 2112166

Group type: EXPERIMENTAL
Intervention: 2% mupirocin ointment (Bactroban)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oral erythromycin ethylsuccinate
Number of subjects: 60
Study: 7044804

Group type: EXPERIMENTAL
Intervention: Fenbufen (600-1000 mg/day, b.i.d.)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Indomethacin (750-125 mg/day, b.i.d.)
Number of subjects: 110
Study: 30705040

Group type: EXPERIMENTAL
Intervention: Intravitreal ziv-aflibercept (IVZ) 1.25 mg/0.05 mL administered 1-10 days before PPV
Number of subjects: 206

Group type: COMPARATOR
Intervention: Intravitreal bevacizumab (IVB) 1.25 mg/0.05 mL administered 1-10 days before PPV
Number of subjects: 206
Study: 29246725

Group type: EXPERIMENTAL
Intervention: Curcumin (Theracurmin® 90 mg twice daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 26707868

Group type: EXPERIMENTAL
Intervention: LHRHa
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: OP (FemSeven 100μg/24h patches)
Number of subjects: 74
Study: 25123822

Group type: EXPERIMENTAL
Intervention: Interactive decision aid
Number of subjects: 131

Group type: COMPARATOR
Intervention: Brochures
Number of subjects: 131
Study: 22715739

Group type: EXPERIMENTAL
Intervention: Dahuang Zhechong Wan combined with adefovir dipivoxil (10 mg of adefovir dipivoxil once a day, 1 Wan each time, combined with Dahuang Zhechong Wan, 3 times a day, 1 Wan each time)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Adefovir dipivoxil alone (control group)
Number of subjects: 94
Study: 19671263

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine with 1:200000 epinephrine (Part I)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Normal saline (Part I)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine with 1:200000 epinephrine (Part II)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Normal saline (Part II)
Number of subjects: 106
Study: 17576400

Group type: EXPERIMENTAL
Intervention: HRT with acetate nomegestrol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Estrogen replacement therapy (ERT)
Number of subjects: 60
Study: 17211120

Group type: EXPERIMENTAL
Intervention: Education class (2 sessions)
Number of subjects: 40
Study: 12439627

Group type: EXPERIMENTAL
Intervention: Alcohol (0.8 g/kg)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Binge drinkers (moderate to heavy use)
Number of subjects: 95
Study: 10813372

Group type: EXPERIMENTAL
Intervention: E 047/1 (amiodarone derivative)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: E 047/1 (high-dose bolus regimen)
Number of subjects: 20
Study: 8829885

Group type: EXPERIMENTAL
Intervention: Epoprostenol (Flolan) 2 ng min-1 kg-1
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Epoprostenol (Flolan) 4 ng min-1 kg-1
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Epoprostenol (Flolan) 8 ng min-1 kg-1
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 1814875

Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 94

Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 94
Study: 6332895

Group type: EXPERIMENTAL
Intervention: Soy isolate formula supplemented with calcium (92 mg/kg/day), phosphorus (44 mg/kg/day), and vitamin D (500 IU/kg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Whey-predominant, low osmolality formula
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 32
Study: 29489408

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiation therapy (CRT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Upfront surgery
Number of subjects: 37
Study: 28615372

Group type: EXPERIMENTAL
Intervention: Iron and Folic Acid (IFA) supplementation
Number of subjects: 1599

Group type: EXPERIMENTAL
Intervention: Multiple Micronutrient (MM) supplementation
Number of subjects: 1599

Group type: COMPARATOR
Intervention: Folic Acid (FA) alone
Number of subjects: 1599
Study: 25740026

Group type: EXPERIMENTAL
Intervention: Periarticular injection
Number of subjects: 71

Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 71
Study: 23958115

Group type: EXPERIMENTAL
Intervention: MISC biweekly caregiver training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Health and nutrition curriculum (active control)
Number of subjects: 60
Study: 20569667

Group type: EXPERIMENTAL
Intervention: Xylitol (not specifically used by participants but mentioned as a potential prophylaxis for AOM)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Adherence to AAP/AAFP guidelines
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Use of complementary and alternative medicine (CAM)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Knowledge and opinions about xylitol
Number of subjects: 98
Study: 17884342

Group type: EXPERIMENTAL
Intervention: Palm oil-rich diet (10 mL of previously boiled crude palm oil once a day for 2 weeks)
Number of subjects: 34
Study: 15726103

Group type: EXPERIMENTAL
Intervention: Annual mammography screening from age 40-41
Number of subjects: 160921

Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 160921
Study: 14562994

Group type: EXPERIMENTAL
Intervention: High-impact exercises (3 times a week for 9 months)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (no high-impact exercises)
Number of subjects: 21
Study: 10476746

Group type: EXPERIMENTAL
Intervention: Imipenem (50 mg/(kg x d))
Number of subjects: 296

Group type: COMPARATOR
Intervention: Ceftazidime (120 mg/(kg x d))
Number of subjects: 296
Study: 8899132

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (50-150 mg/day)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Fluvoxamine (50 mg/day)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study: 1676029

Group type: EXPERIMENTAL
Intervention: Nadolol 40 to 80 mg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6367863

Group type: EXPERIMENTAL
Intervention: Tamoxifen added to L-phenylalanine mustard and 5-fluorouracil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tamoxifen added to L-phenylalanine mustard and 5-fluorouracil in patients >= 50 years old
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tamoxifen added to L-phenylalanine mustard and 5-fluorouracil in patients <= 49 years old
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tamoxifen added to L-phenylalanine mustard and 5-fluorouracil in patients with low estrogen and progesterone levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tamoxifen added to L-phenylalanine mustard and 5-fluorouracil in patients with high estrogen and progesterone levels
Number of subjects: 0
Study: 31819319

Group type: EXPERIMENTAL
Intervention: GLP‐1 infusion (1.5 pmol/kg/min)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (500 mL of 0.9% saline)
Number of subjects: 14
Study: 29039254

Group type: EXPERIMENTAL
Intervention: 0.5mg/kg ketamine infusion
Number of subjects: 55
Study: 24632987

Group type: EXPERIMENTAL
Intervention: Angina pectoris class >2
Number of subjects: 535

Group type: COMPARATOR
Intervention: Angina pectoris class ≤2
Number of subjects: 535
Study: 23817151

Group type: EXPERIMENTAL
Intervention: Long-acting injectable antipsychotics
Number of subjects: 113
Study: 21482191

Group type: EXPERIMENTAL
Intervention: Rasagiline 1 mg
Number of subjects: 1176

Group type: EXPERIMENTAL
Intervention: Rasagiline 2 mg
Number of subjects: 1176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1176
Study: 19185467

Group type: EXPERIMENTAL
Intervention: Escitalopram (10 to 20 mg/day)
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 777

Group type: COMPARATOR
Intervention: Paroxetine (20 to 40 mg/day)
Number of subjects: 777
Study: 17915406

Group type: EXPERIMENTAL
Intervention: Oral hormone replacement therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transdermal hormone replacement therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transdermal regimen
Number of subjects: 0
Study: 15043514

Group type: EXPERIMENTAL
Intervention: Aloe vera gel (100 mL twice daily for 4 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44